The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Standards for Healthcare Service Design and Delivery in the UK for Adults and Children with Crohn’s Disease and Ulcerative Colitis: 2026 Update

  • By

  • Christopher A Lamb

  • Catherine Picton

  • Ian Arnott

  • Pearl Avery

  • Debra Attwood

  • Saswata Banerjee

  • Sarah Bayliss

  • Graham Bell

  • Gauraang Bhatnagar

  • Caroline Brocklehurst

  • Vicky Buckley

  • Valerio Celentano

  • Rachel Dodd

  • Amy Gittins

  • Katie Keetarut

  • Gayle Martin

  • Rafeeq Muhammed

  • Marianne Radcliffe

  • Fiona Rees

  • Ruth Rudling

  • Clare Tibbatts

  • Jessica Turner

  • Catherine Winsor

  • Nathaniel Woo

  • Lisa Younge

  • Christian P Selinger

  • IBD UK Board

  • A Barney Hawthorne

  • April 7, 2026

Share

Clinical Report: Standards for Healthcare Service Design and Delivery in the UK

Overview

The 2026 IBD UK Standards provide an updated framework for the management of Crohn’s disease and ulcerative colitis. The standards include 60 statements across seven domains.

Background

Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, necessitates high-quality, coordinated care. The 2026 update aims to address gaps in care quality.

Data Highlights

Standard CategoryCount
Unchanged6
Updated48
Deleted7
New6

Key Findings

  • The 2026 IBD UK Standards consist of 60 statements across seven domains.
  • Key themes include multidisciplinary care, structured transition pathways, and patient involvement.
  • Timely referrals and access to diagnostics and treatments are emphasized.
  • Patient-centered care is prioritized, including shared decision-making and personalized care plans.
  • Holistic assessment of physical, nutritional, and psychological needs is included.
  • Quality improvement initiatives are supported by electronic systems and research participation.

Clinical Implications

The 2026 IBD UK Standards provide a framework for healthcare providers to enhance service delivery for patients with IBD.

Conclusion

The updated IBD UK Standards serve as a framework for delivering high-quality care to individuals with Crohn’s disease and ulcerative colitis.

Related Resources & Content

  1. BMJ Open Gastroenterology, 2026 -- The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis
  2. Journal of Gastroenterology, 2012 -- Clinical Practice Guidelines for Crohn’s Disease Based on Evidence and Expert Consensus in Japan
  3. Journal of Gastroenterology, 2020 -- National Overview of Surgical Interventions for Colonic Crohn's Disease
  4. Journal of Gastroenterology, 2018 -- Current Advances in the Management of Crohn’s Disease
  5. The New Gastroenterologist, 2025 -- AGA Releases Updated Clinical Guidelines for Managing Moderate-to-Severe Crohn’s Disease
  6. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment, 2024
  7. The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis | BMJ Open Gastroenterology
  8. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment | Journal of Crohn's and Colitis | Oxford Academic
  9. Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials - ScienceDirect

Original Source(s)

The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis

  • by Christopher A Lamb, Catherine Picton, Ian Arnott, Pearl Avery, Debra Attwood, Saswata Banerjee, Sarah Bayliss, Graham Bell, Gauraang Bhatnagar, Caroline Brocklehurst, Vicky Buckley, Valerio Celentano, Rachel Dodd, Amy Gittins, Katie Keetarut, Gayle Martin, Rafeeq Muhammed, Marianne Radcliffe, Fiona Rees, Ruth Rudling, Clare Tibbatts, Jessica Turner, Catherine Winsor, Nathaniel Woo, Lisa Younge, Christian P Selinger, IBD UK Board, A Barney Hawthorne

  • April 7, 2026

Related Content

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study

Creation and assessment of a predictive model utilizing choroid plexus imaging from brain MRI for evaluating anti-TNF-α treatment responses in Crohn’s disease

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.